Evidence map›Paper›PMID 41240075›Full record

ArticlePsychopharmacology2026

(R)-Ketamine reduces alcohol intake and alcohol seeking induced by reconsolidation of alcohol-related memories in female Marchigian Sardinian alcohol-preferring rats.

Elisabetta Ciccocioppo, Sara Massetti, Marcus W Meinhardt, Fabio Fumagalli, Patrizia Romualdi, Marisa Roberto, Rainer Spanagel, Roberto Ciccocioppo, Esi Domi

Abstract read
In one paragraph

Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elisabetta Ciccocioppo *School of Pharmacy, Pharmacology Unit, Centre for Neuroscience, University of Camerino, Via Madonna delle Carceri 9, Camerino, MC, 62032, Italy.
Sara Massetti *School of Pharmacy, Pharmacology Unit, Centre for Neuroscience, University of Camerino, Via Madonna delle Carceri 9, Camerino, MC, 62032, Italy.
Marcus W MeinhardtInstitute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Fabio FumagalliDepartment of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano, Milan, 20133, Italy.
Patrizia RomualdiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Irnerio 48, Bologna, 40126, Italy.
Marisa RobertoDepartment of Translational Medicine, Scripps Research Institute, La Jolla, CA, 92037, US.
Rainer SpanagelInstitute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Roberto CiccocioppoSchool of Pharmacy, Pharmacology Unit, Centre for Neuroscience, University of Camerino, Via Madonna delle Carceri 9, Camerino, MC, 62032, Italy. roberto.ciccocioppo@unicam.it.
Esi DomiSchool of Pharmacy, Pharmacology Unit, Centre for Neuroscience, University of Camerino, Via Madonna delle Carceri 9, Camerino, MC, 62032, Italy. esi.domi@unicam.it.ORCID http://orcid.org/0000-0001-5726-4814

Funding

The Nociceptin ORL1 System: Treatment Target for RelapseR01AA014351 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI Friedbert Weiss · 2004 to 2026
$7.3M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR37AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2016 to 2025
$3.7M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR01AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2009 to 2013
$1.8M
Deutsche Forschungsgemeinschaft TRR 265ERA-NET Neuron Psi-Alc FKZ: 01EW1908Eva-Maria and Rutger Hetzler Foundation grant Psy-Alc Eva-Maria and Rutger Hetzler Foundation grant Psy-AlcMIUR Progetto Eccellenza 2023-2027 MIUR Progetto Eccellenza 2023-2027NIAAA NIH HHS AA014351NIAAA NIH HHS AA017447NIAAA NIH HHS R01 AA014351NIAAA NIH HHS R01 AA017447NIAAA NIH HHS R37 AA017447PRIN 2022 2022B5RMW9PRIN PNRR 2022 P2022ZXF98PRIN-PNRR2022 -P202274WPN, PRIN-2022 20227HRFPJ PRIN-PNRR2022 -P202274WPN, PRIN-2022 20227HRFPJProject MNESYS - Project AMSUD 2024 PE0000006
6 · The paper itself

Abstract

backgroundAlcohol use disorder (AUD) represents a significant medical challenge, with available therapeutic approaches having limited efficacy. Emerging data suggest that psychedelic compounds could represent an alternative treatment for AUD. Among this class of molecules, ketamine, a dissociative psychedelic, shows promising properties. It reduces alcohol drinking in rodents and in humans it is used to treat depression, a condition often comorbid with AUD. Unfortunately, the marked dissociative and anesthetic effects of this molecule severely limit its therapeutic application. Ketamine is a racemic mixture of (S, R)-enantiomers, and the R-enantiomer possesses lower dissociative and anesthetic properties compared to the racemic mixture. 

methodsHere, using male and female genetically selected Marchigian Sardinian alcohol-preferring (msP) rats, we evaluated the potential efficacy of (R)-ketamine, in alcohol-related behaviours including home cage voluntary drinking and alcohol self-administration. We also evaluated whether R ketamine may affect the reconsolidation process of alcohol-related memories.

resultsIn the two-bottle free choice (free choice between 10% alcohol and water) 24-h drinking paradigm R-ketamine given orally (10, 20 and 40 mg/kg) significantly reduced alcohol consumption in female but not in male rats. No effect was observed on alcohol self-administration. We subsequently tested (R)-ketamine on alcohol memory consolidation/ retrieval task and found a significant attenuation in the retrieval of alcohol-related memories in female but not in male msP rats.

conclusionsTaken together, our findings indicate that (R)-ketamine attenuates alcohol-related behaviors in a sex-dependent manner with females showing a higher sensitivity to its effects. Given its more favorable safety profile compared to the racemic mixture, these results support the clinical investigation of (R)-ketamine as a therapeutic intervention in patients with AUD. Particular attention should be paid to sex-specific effects observed with (R)-ketamine, as they may have important clinical implications.

Indexed as

Alcohol DrinkingDrug-Seeking BehaviorKetamineMemoryAnimalsDose-Response Relationship, DrugEthanolFemaleMaleRatsSelf AdministrationStereoisomerismEthanolKetamineAlcohol use disorder (AUD)Memory retrievalPsychedelics(R)-ketamine

Identifiers

PMID41240075
PMCPMC13086072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.